Carpro-AM1

• Description :

  Carpro-AM1 is a dual-acting FAAH/substrate-selective COX inhibitor with an IC50 value of 94 nM for FAAH[1].

• UNSPSC :

  12352005

• Target :

  COX; FAAH

• Type :

  Reference compound

• Related Pathways :

  Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Cancer; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease

• Assay Protocol :

  https://www.medchemexpress.com/carpro-am1.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(C(C)C1=CC(NC2=CC=C(C=C23)Cl)=C3C=C1)NC4=NC=CC=C4C

• Molecular Formula :

  C21H18ClN3O

• Molecular Weight :

  363.84

• References & Citations :

  [1]Deplano A, et al. The fatty acid amide hydrolase and cyclooxygenase-inhibitory properties of novel amide derivatives of carprofen. Bioorg Chem. 2020 Aug;101:104034.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2499489-76-6]